Pmv Pharmaceuticals Inc

$23.16 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Pmv Pharmaceuticals Inc

PMV Pharmaceuticals, Inc. is a precision oncology company. The Company is focused on discovering and developing small molecule, tumor-agnostic therapies targeting p53 mutations. It’s lead product candidate, PC14586, is designed to potently and selectively correct p53 misfolding caused by a specific p53 mutation, Y220C, while sparing wild-type p53. It is also using its precision oncology platform to develop a pipeline of oral small molecule product candidates that structurally correct other p53 hotspot mutations to restore their wild-type function. Its second program, R273H, targets the p53 R273H hotspot mutation.

Stock Analysis

last close $23.16
1-mo return -15.6%
3-mo return -34.8%
avg daily vol. 322.19T
52-week high 63.22
52-week low 22.59
market cap. $1.1B
forward pe -
annual div. -
roe -34.6%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 88%

Subscribe now for daily local and international financial news